Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Times Interest Earned (2022 - 2026)

TriSalus Life Sciences has reported Times Interest Earned over the past 5 years, most recently at -$5.86 for Q1 2026.

  • For Q1 2026, Times Interest Earned rose 3.38% year-over-year to -$5.86; the TTM value through Mar 2026 reached -$4.86, up 34.43%, while the annual FY2025 figure was -$4.86, 58.47% up from the prior year.
  • Times Interest Earned for Q1 2026 was -$5.86 at TriSalus Life Sciences, down from -$2.25 in the prior quarter.
  • Over five years, Times Interest Earned peaked at -$2.25 in Q4 2025 and troughed at -$11772.0 in Q4 2022.
  • A 5-year average of -$2142.7 and a median of -$8.49 in 2024 define the central range for Times Interest Earned.
  • On a YoY basis, Times Interest Earned climbed as much as 99.85% in 2024 and fell as far as 92.21% in 2024.
  • Year by year, Times Interest Earned stood at -$11772.0 in 2022, then soared by 59.66% to -$4749.3 in 2023, then surged by 99.85% to -$7.1 in 2024, then soared by 68.26% to -$2.25 in 2025, then crashed by 160.0% to -$5.86 in 2026.
  • Business Quant data shows Times Interest Earned for TLSI at -$5.86 in Q1 2026, -$2.25 in Q4 2025, and -$6.17 in Q3 2025.